Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Beuren Syndrome

fluorodeoxyglucose f18 has been researched along with Beuren Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chrapko, B; Jaszczuk, L; Lejman, M; Opoka-Winiarska, V; Rybkowska, A; Sobiesiak, A; Tomaszek, MB; Woźniak, MM; Zielonka-Lamparska, E1
Byoun, JT; Cho, JY; Oh, SJ; Rhee, SJ; Yu, ST; Yun, KH1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Beuren Syndrome

ArticleYear
The importance of FDG PET/CT in the diagnostic process of the middle aortic syndrome in a 15-year-old boy patient with suspected systemic vasculitis and final diagnosis of Williams-Beuren syndrome.
    Rheumatology international, 2020, Volume: 40, Issue:8

    Topics: Adolescent; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Takayasu Arteritis; Williams Syndrome

2020

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Beuren Syndrome

ArticleYear
Mid-Aortic Syndrome in Williams-Beuren Syndrome with an Atypical Small-Sized Deletion of Chromosome 7q11.23 Misdiagnosed as Takayasu Arteritis.
    International heart journal, 2021, Jan-30, Volume: 62, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Aorta; Aortography; Chromosome Deletion; Computed Tomography Angiography; Diagnostic Errors; Drug Therapy, Combination; Echocardiography; Fluorodeoxyglucose F18; Humans; Hypertension; Male; Microarray Analysis; Positron-Emission Tomography; Takayasu Arteritis; Treatment Outcome; Williams Syndrome

2021